Category: Biotherapeutic Index

Mucosa compositum ad us. vet. Injection Solution 5.0 ml

Mucosa compositum Heel Injection Solution 2.2 ml

Composition:

Mucosa compositum ad us. vet.: 1 ampoule of 5.0 ml contains: Mucosa nasalis suis D8; Mucosa oris suis D8; Mucosa pulmonis suis D8; Mucosa oculi suis D8; Mucosa vesicae felleae suis D8; Mucosa pylori suis D8; Mucosa duodeni suis D8; Mucosa oesophagi suis D8; Mucosa jejuni suis D8; Mucosa ilei suis D8; Mucosa coli suis D8; Mucosa recti suis D8; Mucosa ductus choledochi suis D8; Mucosa vesicae urinariae suis D8; Ventri- culus suis D8; Pankreas suis D10; Argentum nitricum D6; Atropa belladonna D10; Oxalis acetosella D6; Semecarpus anacardium D6; Phosphorus D8; Lachesis mutus D10; Ipecacuanha D8; Nux vomica D13; Veratrum album D4; Pulsatilla pratensis D6; Kreosotum D10; Sulfur D8; Bacterium coli-Nosode D28; Marsdenia cundurango D6; Kalium bichromicum D8; Hydrastis canadensis D4; Mandragora e radice siccato D10; Momordica balsamina D6; Ceanothus americanus D4; Natrium diethyloxalaceticum D8 0.05 ml each.

Mucosa compositum Heel: 1 ampoule of 2.2 ml (= 2.2 g) contains: Mucosa nasalis suis D8, Mucosa oris suis D8, Mucosa pulmonis suis D8, Mucosa oculi suis D8, Mucosa vesicae felleae suis D8, Mucosa vesicae urinariae suis D8, Mucosa pylori suis D8, Mucosa duodeni suis D8, Mucosa oesophagi suis D8, Mucosa jejuni suis D8, Mucosa ilei suis D8, Mucosa coli suis D8, Mucosa recti suis D8, Mucosa ductus choledochi suis D8, Ventriculus suis D8, Pankreas suis D10, Argentum nitricum D6, Atropa belladonna D10, Oxalis acetosella D6, Semecarpus anacardium D6, Phosphorus D8, Lachesis mutus D10, Cephaelis ipecacuanha D8, Strychnos nux-vomica D13, Veratrum album D4, Pulsatilla pratensis D6, Kreosotum D10, Sulfur D8, Natrium diethyloxalaceticum D8, Marsdenia cundurango D6, Kalium bichromicum D8, Hydrastis canadensis D4, Mandragora e radice siccato D10, Momordica balsamina D6, Ceanothus americanus D4 22 mg each.

Indications:

Mucosal disorders and catarrhs of different type and localisation, e. g. in the alimen- tary tract, upper and lower respiratory tract, uriniferous tract, conjunctiva of the eye, panleucopenia, Herpes-rhinovirus-infection, Parvovirus-infection, chronic enteritis, oti- tis, conjunctivitis, endometritis. Supportive to the specific therapy.

Contraindications: First trimenon of pregnancy.

Side effects: Skin reactions may occur in individual cases, in which case use of the product should be discontinued. Phenol allergy.

Interaction with other medications: None known.

Waiting period: None.

Instructions for use, route and duration of administration:

Mucosa compositum ad us. vet. is to be administered by s.c. or i.v. injection.

According to species, the daily single dosage is as follows:

Horse, cattle, swine: 5 ml

Piglet: 2–3 ml

Sheep, goat: 2 ml

Large dog: 3–4 ml

Medium dog: 2 ml

Small dog, cat: 1–2 ml

Puppy: 0.5–1 ml

Small pets: 0.5 ml

In cases with acute symptoms, the indicated dosage can be repeated after a period of 24 hours.

For treatment of disorders with tendencies to recur, chronic affections or long-term treatment, the indicated single dosage can be administered at 4-day intervals.

Dosage: Mucosa compositum Heel injection solution 2.2 ml:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Mucosa compositum ad us. vet.: Packs containing 5 or 50 ampoules of 5.0 ml each. Mucosa compositum Heel: Packs containing 10 or 50 ampoules of 2.2 ml each.

Tablets

Composition:

1 tablet cont.: Mercurius solubilis Hahnemanni D10 90 mg; Hepar sulfuris D8, Lachesis mutus D12, Phytolacca americana D4, Ailanthus altissima D3, Echinacea angustifolia D3 30 mg each; Atropa belladonna D4 60 mg.

Indications:

Furuncles, carbuncles and other suppurations, including, e.g. those in the (peri)-ton- sillar tissue.

Contraindications: Hypersensitivity to one of the active ingredients or excipients, or to plants of the composite family. As a matter of principle, Echinacea should not be used in progressive, systemic diseases such as tuberculosis, leukemia or leukemia-like dis- eases, inflammatory diseases of the connective tissue (collagen disease), autoimmune diseases, multiple sclerosis, AIDS, HIV infections or other chronic viral diseases.

Side effects: Hypersalivation may occur after administration, in which case the use of this product should be discontinued. Hypersensitivity reactions can occur in individual cases. Skin rash and itching (pruritus), and in rare cases facial swelling, shortness of breath (dyspnea), dizziness and a fall in blood pressure, have been observed after treatment with products containing Echinacea extracts. Allergic reactions may occa- sionally occur on account of the homeopathic active substance Mercurius solubilis, too.

Interaction with other medications: None known.

Dosage:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Packs containing 50 and 250 tablets.

Injection Solution 1.1 m

Drops

Composition:

Lymphomyosot N injection solution: 1 ampoule of 1.1 ml (1.1 g) contains: Myosotis arvensis D3, Veronica officinalis D3, Teucrium scorodonia D3, Pinus sylvestris D4, Gen- tiana lutea D5, Equisetum hyemale D4, Smilax D6, Scrophularia nodosa D3, Calcium phosphoricum D12, Natrium sulfuricum D4, Fumaria officinalis D4, Levothyroxinum D12, Araneus diadematus D6 0.55 mg each; Geranium robertianum D4, Nasturtium officinale D4, Ferrum jodatum D12 1.1 mg each.

Lymphomyosot N drops: 100 g cont.: Myosotis arvensis D3, Veronica officinalis D3, Teucrium scorodonia D3, Pinus sylvestris D4, Gentiana lutea D5, Equisetum hyemale D4, Smilax D6, Scrophularia nodosa D3, Calcium phosphoricum D12, Natrium sulfuri- cum D4, Fumaria officinalis D4, Levothyroxinum D12, Araneus diadematus D6 5 g each; Geranium robertianum D4, Nasturtium officinale D4, Ferrum jodatum D12 10 g each. Contains 35 vol.-% alcohol.

Indications:

Lymphatism (tendency to hypertrophy of the lymphatic organs, tendency to formation of edemas and to susceptability to infection); glandular swelling; tonsillar hypertrophy and chronic tonsillitis.

Contraindications: Do not use in thyroid conditions without seeking medical advise.

Side effects: (Injection solution) Hypersensitivity reactions (or even anaphylactic reac- tions) may occur in isolated instances on the i.v. administration of foreign proteins in a concentration higher than D10.

Interaction with other medications: None known.

Dosage:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Lymphomyosot N injection solution: Packs containing 10 or 50 ampoules of 1.1 ml each.

Lymphomyosot N drops: Drop bottles containing 30 or 100 ml.

Injection Solution 2.2 ml

Drops

Leptandra compositum Injection Solution 2.2 ml Drops

Composition:

Injection solution: 2.2 ml (=2.2 g) cont.: Veronica virginica D2, Picrasma excelsa, Quas- sia amara D3, Podophyllum peltatum D3, Acidum arsenicosum D4, Carbo vegetabilis D10, Niccolum metallicum D10, Phosphorus D6 22 mg each.

Drops: 100 g cont.: Veronica virginica D2, Picrasma excelsa, Quassia amara D3, Podo- phyllum peltatum D3, Acidum arsenicosum D4, Carbo vegetabilis D10, Niccolum me- tallicum D10, Phosphorus D6 1g each. Contains 35 vol.-% alcohol.

Indications:

Stimulation of the endogenic defense system in epigastric syndrome, particularly in chronic diseases of the liver and pancreas or in acute attacks (e.g. after dietary indiscre- tions); physiosis (abdominal distension); congestion of the portal vein.

Contraindications: Do not use during pregnancy and lactation.

Side effects: None known.

Interaction with other medications: None known.

Dosage:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Injection solution: Packs containing 10 or 50 ampoules of 2.2 ml each. Drops: Drop bottles containing 30 and 100 ml.

Injection Solution 5.0 ml

Composition:

1 ampoule of 5.0 ml contains: Lachesis mutus D6 200 mg; Pyrogenium-Nosode D6 200 mg; Juniperus sabina D3 100 mg; Echinacea angustifolia D1 100 mg; Pulsatilla praten- sis D2 50 mg.

Indications:

Mastitis-Metritis-Agalactia (MMA) in sows. Puerperal disorders.

Contraindications: None known.

Side effects: Hypersensitivity reactions (or even anaphylactic reactions) may occur in isolated instances on the i.v. administration of foreign proteins in a concentration high- er than D10.

Interaction with other medications: None known.

Waiting period: None.

Instructions for use, route and duration of administration:

Lachesis compositum N ad us. vet. is to be administered by s.c., i.m. or i.v. injection.

According to species, the single dosage is as follows:

Horse, cattle, swine: 5 ml

Sheep, goat: 2 ml

Large dog: 3–4 ml

Medium dog: 2 ml

Small dog, cat: 1–2 ml

Small pets: 0.5 ml

If necessary, depending on the severity of the case, the indicated dosage is to be repeat- ed after 24 hours.

Package sizes:

Packs containing 5 or 50 ampoules of 5.0 ml each.

Hormeel® QP ad us. vet. Injection Solution 5.0 ml

Hormeel® SN  Injection Solution 1.1 ml

Hormeel® S Drops

Composition:

Hormeel QP ad us. vet. injection solution: 1 ampoule of 5.0 ml contains: Hormeel QP ad us. vet. injection solution: 1 ampoule of 5.0 ml (= 5 g) contains: Acidum nitricum D4, Conyza canadensis D4, Viburnum opulus D4, Pulsatilla pratensis D4, Cyclamen purpurascens D4, Strychnos ignatii D6 2.5 mg each; Aquilegia vulgaris D4, Origanum majorana D4, Myristica fragrans D6, Calcium carbonicum Hahnemanni D8 5 mg each; Sepia officinalis D6 250 mg.

Hormeel SN injection solution: 1 ampoule of 1.1 ml (= 1.1 g) contains: Acidum nitricum D4, Conyza canadensis D3, Viburnum opulus D3, Pulsatilla pratensis D4, Cyclamen purpurascens D4, Strychnos ignatii D6, Sepia officinalis D6 0.55 mg each; Aquilegia vulgaris D4, Origanum majorana D4, Myristica fragrans D6, Calcium carbonicum Hah- nemanni D8 1.1 mg each.

Hormeel S drops: 100 g cont.: Senecio nemorensis ssp. fuchsii D6, Acidum nitricum D4, Erigeron canadensis D3, Moschus moschiferus D6, Viburnum opulus D3, Pulsatilla pra- tensis D4, Sepia officinalis D6, Cyclamen europaeum D4, Ignatia D6, Thlaspi bursa pastoris D3 5 g each; Calcium carbonicum Hahnemanni D8, Aquilegia vulgaris D4, Cypripedium calceolus var. pubescens D8, Origanum majorana D4, Nux moschata D6 10 g each. Contains 35 vol.-% alcohol.

Indications:

Functional disorders in the female cycle, fluor albus (white vaginal discharge), chronic endometritis, pyometra, false pregnancy, nymphomania.

Contraindications: None known.

Side effects: (Injection solutions) Hypersensitivity reactions (or even anaphylactic reac- tions) may occur in isolated instances on the i.v. administration of foreign proteins in a concentration higher than D10.

Interaction with other medications: None known.

Waiting period: None.

Instructions for use, route and duration of administration:

Hormeel QP ad us. vet. is to be administered by s.c. or i.v. injection.

For acute symptoms, the indicated dosage is to be repeated after 4 days and, if re- quired, after 20 days.

Dosage: Hormeel SN injection solution 1.1 ml, Hormeel S drops:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Hormeel QP ad us. vet. injection solution: Packs containing 5 or 50 ampoules of 5.0 ml each. Do not store above 30 °C.

Hormeel SN injection solution: Packs containing 10 or 50 ampoules of 1.1 ml each. Hormeel S drops: Drop bottles containing 30 or 100 ml.

Injection Solution 1.1 ml

Tablets

Composition:

Injection solution: 1.1 ml (=1.1 g) cont.: Chelidonium majus D6 1.1 mg; Phosphorus D5 0.55 mg; Veratrum album D5 2.2 mg; Citrullus colocynthis D5 3.3 mg; Lycopodium clavatum D2, Cinchona pubescens D2, Myristica fragrans D3 1.1 mg each; Silybum marianum D1 0.55 mg.

Tablets: 1 tablet cont.: Chelidonium D6, Nux moschata D4 30 mg each; Phosphorus D6 15 mg; Veratrum D6 60 mg; Colocynthis D6 90 mg; Lycopodium D3, China D3 30 mg each; Carduus marianus D2 15 mg.

Indications:

Primary and secondary functional disorders of the liver; damaged liver.

Contraindications: Because of the constituents Celandine (Chelidonium) and Veratrum do not use during pregnancy and lactation. Do not use in case of hypersensitivity to Carduus marianus or other plants of the daisy family.

Side effects: In rare cases, reactions of hypersensitivity such as skin allergy or fever may occur after exposure to drugs that contain quinine. In such cases, you must see a doc- tor. Note: A quinine or quinidine sensitization may occur.

Interaction with other medications: None known.

Dosage:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Injection solution: Packs containing 10 or 50 ampoules of 1.1 ml each. Tablets: Packs containing 50 and 250 tablets.

Injection Solution 2.2 ml

Composition:

1 ampoule of 2.2 ml (2.2 g) contains: Hepar suis D8, Cyanocobalaminum D4, Duode- num suis D10, Thymus suis D10, Colon suis D10, Vesica fellea suis D10, Pankreas suis D10, Cinchona pubescens D4, Lycopodium clavatum D4, Chelidonium majus D5, Sily- bum marianum D3, Histaminum D10, Sulfur D13, Avena sativa D6, Natrium diethy- loxalaceticum D10, Acidum alpha-ketoglutaricum D10, Acidum DL-malicum D10, Aci- dum fumaricum D10 Calcium carbonicum Hahnemanni D28,, Taraxacum officinale D4, Cynara scolymus D6, Veratrum album D4, Acidum alpha-liponicum D8, Acidum oroti- cum D6 22 mg each.

Indications:

Stimulation of the detoxicating function of the liver in acute and chronic diseases of the liver/gall, e.g. cholangitis and cholecystitis; in functional disorders of the liver of

toxic origin as cause or result of other diseases, in hypercholesteremia, erythematodes, toxic exanthema, dermatosis and dermatitis, neurodermitis and for the stimulation of the liver cell functioning.

Contraindications: Do not use in case of hypersensitivity to Carduus marianus (milk thistle), or Taraxacum officinale (dandelion) or Cynara scolymus (artichoke) or other plants of the daisy family. Because of the constituents Celandine (Chelidonium) and Veratrum do not use during pregnancy and lactation.

Side effects: In rare cases, reactions of hypersensitivity such as skin allergy or fever may occur after exposure to drugs that contain quinine. In such cases, you must see a doc- tor. Note: A quinine or quinidine sensitization may occur.

Interaction with other medications: None known.

Dosage:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Packs containing 10 or 50 ampoules of 2.2 ml each.

Drops

Composition:

100 g cont.: Apis mellifica D4, Ammonium bromatum D4, Lilium lancifolium D4, Au- rum iodatum D12, Crabro vespa D4, Chamaelirium luteum D4, Palladium metallicum D12, Platinum metallicum D12 10 g each; Melilotus officinalis D3, Viburnum opulus D2 5 g each. Contains 35 vol.-% alcohol.

Indications:

Inflammatory conditions of the female genital organs, e.g. myometritis, endometritis. Mammary edema in bitches.

Contraindications: Do not use in hypersensitivity to bee, wasp or Hornet venom. Do not use in thyroid conditions without seeking medical advice.

Side effects: None known.

Interaction with other medications: None known.

Dosage:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Drop bottles containing 30 and 100 ml.

Injection Solution 1.1 ml

Tablets

Composition:

Injection solution: 1.1 ml (=1.1 g) cont.: Aconitum napellus D3 4.4 mg; Eupatorium perfoliatum D2, Phosphorus D4 1.1 mg each; Lachesis mutus D11, Bryonia D3 2.2 mg each.

Tablets: 1 tablet cont.: Aconitum napellus D4 120 mg; Bryonia D4, Lachesis mutus D12 60 mg each; Eupatorium perfoliatum D3, Phosphorus D5 30 mg each.

Indications:

Influenza and influenzal infections and for the stimulation of the endogenic defense system in other feverish infectious diseases.

Contraindications: None known.

Side effects: None known.

Interaction with other medications: None known.

Dosage:

See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.

Package sizes:

Injection solution: Packs containing 10 or 50 ampoules of 1.1 ml each. Tablets: Packs containing 50 and 250 tablets.